Graves' orbitopathy following Alemtuzumab treatment for multiple sclerosis: a systematic review and real-world insights. [PDF]
Patera B +5 more
europepmc +1 more source
Pure Endoscopic Orbital Decompression in Graves' Orbitopathy: A Comprehensive Retrospective Analysis of Objective and Subjective Outcomes. [PDF]
Almanzo S +6 more
europepmc +1 more source
Graves’ Orbitopathy and Oxidative Stress [PDF]
C. Novembrino +4 more
openaire +3 more sources
Real world effectiveness of Mycophenolate-sodium therapy in patients at risk with Graves' orbitopathy. [PDF]
Sander J +6 more
europepmc +1 more source
Volumetric Analysis of Navigation-Guided Orbital Decompression in Graves' Orbitopathy: A Case Report. [PDF]
Ruiz-de-Leon G +10 more
europepmc +1 more source
Risk factors and outcomes of Graves' orbitopathy after radioactive iodine therapy. [PDF]
Ahn HY, Lee J, Kim M, Lee JK.
europepmc +1 more source
Serum Biomarkers Linked to Disease Activity, Severity, and Methylprednisolone Response in Graves' Orbitopathy: A Proteomic Study. [PDF]
Hötte GJ +10 more
europepmc +1 more source
Retraction: Preliminary Evidence From an Original Study Suggests Combustion, Not Nicotine, Drives Risk and Complications of Graves' Orbitopathy. [PDF]
Acanfora M, Vassallo A.
europepmc +1 more source
Unilateral Graves' Orbitopathy Followed by Hashimoto's Hypothyroidism: Highlighting Micronutrient Influence in Thyroid Autoimmunity. [PDF]
Kermaj M +4 more
europepmc +1 more source
Age-dependent diagnostic and treatment response prediction of TBII and TSI in Graves' orbitopathy: integration with orbital MRI biomarkers. [PDF]
Song C +11 more
europepmc +1 more source

